目的:观察清脂化瘀汤治疗非酒精性脂肪肝的临床疗效.方法:将90例非酒精性脂肪肝患者随机分为治疗组和对照组各45例,对照组在常规治疗的基础上加用辛伐他汀片治疗,治疗组在对照组治疗基础上加用中药清脂化瘀汤治疗,比较两组肝功能及B超改善情况.结果:治疗组肝功能和B超改善情况均明显优于对照组(P<0.05);总有效率治疗组为84.4%,对照组为66.7%,组间比较,差异有统计学意义(P<0.05).结论:应用清脂化瘀汤治疗非酒精性脂肪肝具有良好的效果.
[目的]观察中药离子导入联合常规治疗肝郁脾虚慢性乙型病毒性肝炎疗效.[方法]使用随机平行对照方法,将60例住院和门诊患者按就诊顺序编号简单随机分为两组.对照组30例抗病毒、护肝降酶、中药对症等常规治疗.治疗组30例肝病治疗仪中药离子导入.选穴:阳陵泉、足三里、阴陵泉、阿是穴、肝俞、期门、章门;离子导入:柴胡、白术各150g,水煎350mL,放入烧杯中,通过电热恒温水箱加热至100℃浓缩成300mL,10mL/次,用2×2cm纱布浸取药汁贴于肝病治疗仪电极板上,嘱患者平卧位或坐位,照上述穴位放置,Ⅰ、Ⅱ、Ⅲ三个频率交替使用,以Ⅰ频为主,30min/次,1次/d,6次/周;常规治疗同对照组.连续治疗4周为1疗程.观测临床症状、肝功能指标(ALT、AST、TBIL)、症状积分、不良反应.治疗1疗程,判定疗效.[结果]治疗组痊愈7例,有效21例,无效2例,总有效率93.33%.对照组痊愈4例,有效20例,无效5例,总有效率80.00%.治疗组疗效优于对照组(P<0.05).临床症状积分、肝功能指标(ALT、AST、TBIL)两组均有改善(P<0.01),治疗组改善优于对照组(P<0.05).[结论]中药离子导入联合常规治疗肝郁脾虚型慢性乙型病毒性肝炎,疗效满意,无严重不良反应,值得推广.
Objective To investigate the clinical efficacy of Diammonium Glycyrrhizinate Injection combine with compound Biejia Ruangan tablets in hepatofibrosis of Chronic Hepatitis B. Methods 60 patients with hepatofibrosis were randomly divided into two groups. The experimental group was treated with Diammonium Glycyrrhizinate injection and compound Biejia Ruangan tablets for 4 weeks, and the control group was treated with Potassium Magmesium Aspartate and Colchicine for 4 weeks without taking anti-fibrosis and immunoregulation medication. Hepatic function and the degree of hepatofibrosis were compared between the two groups. Results In the treatment group, hepatic function and the degree of hepatofibrosis were significantly better than the control group (P<0.05). Conclusion Diammonium Glycyrrhizinate Injection combination Fufang Biejia Ruangan Table could treat hepatofibrosis induced by Chronic Hepatitis B effectively and counteract hepatofibrosis commendably and prevented the further development to hepatic cirrhosis.